Fundraising Fox
T-Cypher Bio
5 known investors
Find your way into T-Cypher Bio
Sign up to see every warm intro you have to T-Cypher Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the T-Cypher Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
T-Cypher Bio develops drugs with curative potential, focusing on antibody development, T cell biology, and TCR discovery. The company applies immunology and AI-driven approaches in the biotech sector.
Investors · 5
Future Planet Capitallisted by Future Planet CapitalLondon
How we know: Future Planet Capital's portfolio page · the VCSheet dataset · Not right? Tell us
LifeArc Ventureslisted by LifeArc VenturesLondon
How we know: LifeArc Ventures's portfolio page · Not right? Tell us
In the news
Frequently asked questions
- What does T-Cypher Bio do?
- T-Cypher Bio develops drugs with curative potential, focusing on antibody development, T cell biology, and TCR discovery. The company applies immunology and AI-driven approaches in the biotech sector.
- Who are T-Cypher Bio's investors?
- T-Cypher Bio's investors include Future Planet Capital, LifeArc Ventures, Oxford Science Enterprises, Perivoli Innovations, Medicxi.